CLINICIAN REVIEWEDEVIDENCE-BASED

High cholesterol

High cholesterol usually means that one or more blood lipid measurements are outside a healthy range, especially low-density lipoprotein (LDL) cholesterol. High LDL contributes to atherosclerosis and raises the risk of heart attack, stroke and other cardiovascular disease.

At a glance

Quick facts

Condition snapshot
Category
Lipid disorder / CVD risk factor
Typical symptoms
Usually none
Main test
Lipid panel
Key measure
LDL / non-HDL cholesterol
Major complication
Atherosclerotic cardiovascular disease
Common treatment
Lifestyle ± lipid-lowering medicine
Medically reviewed

Dr. Augustine Chinemerem Anadu

Consultant Family Physician · University of Calabar Teaching Hospital

Reviewed for clinical accuracy, practical wording and general-medicine context.

Names & terminology

How this entity may be named or searched

LDL cholesterol
Often called “bad” cholesterol because higher levels promote cholesterol deposition in artery walls.
HDL cholesterol
Often called “good” cholesterol; it is one part of cardiovascular risk assessment, not a treatment target by itself.
Dyslipidemia
A broader term for unhealthy levels or patterns of cholesterol and/or triglycerides.

Structured entity profile

Clinical profile

Condition data
NatureUsually silentHigh LDL cholesterol typically causes no symptoms.
DetectionBlood testingA lipid panel measures total cholesterol, LDL, HDL and triglycerides.
RiskAtherosclerotic cardiovascular diseaseRisk depends on lipid levels together with age, blood pressure, smoking, diabetes, kidney disease and existing CVD.
Secondary causesImportant to considerHypothyroidism, diabetes, kidney disease, medicines and other conditions can alter lipid levels.
Inherited diseaseFamilial hypercholesterolemiaVery high LDL from an inherited disorder can cause premature cardiovascular disease.
TreatmentRisk-basedLifestyle and statins are common; additional medicines may be used when risk remains high or statins are insufficient or not tolerated.

Overview

Cholesterol is carried in the blood within lipoproteins. High LDL cholesterol can contribute to plaque buildup in arteries, while a lipid panel also reports HDL cholesterol and triglycerides. The clinical importance of any single value depends on the person’s overall cardiovascular risk. [1]

“High cholesterol” is therefore not a single uniform diagnosis. A person may have high LDL, high triglycerides, low HDL, an inherited lipid disorder or a combination of these patterns, and management should match the underlying pattern and cardiovascular risk. [1] [2]

Symptoms and warning signs

High LDL cholesterol usually causes no symptoms and is commonly discovered through routine blood testing. Very high inherited cholesterol can sometimes produce xanthomas or corneal arcus, but most people have no visible signs before cardiovascular disease develops. [1]

SYMPTOM MATRIX

High cholesterol is usually a laboratory finding

Most people feel well; the clinically important issue is long-term cardiovascular risk.

Lipid profile
Typical pattern
  • No symptoms
  • Abnormal lipid panel
  • High LDL or non-HDL cholesterol
  • Often found during routine screening
Risk / inherited clues
  • Family history of early heart disease
  • Very high LDL cholesterol
  • Xanthomas in severe inherited disease
  • Diabetes, kidney disease or hypothyroidism
Urgent complications
  • New chest pressure or pain
  • Sudden weakness or speech difficulty
  • Acute shortness of breath
  • Other symptoms of heart attack or stroke

High cholesterol itself is usually silent, but acute cardiovascular symptoms require emergency assessment.

Diagnosis

A lipid panel typically reports total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides. A clinician interprets the pattern together with age, family history and other cardiovascular risk factors rather than using one number in isolation. [1]

When LDL cholesterol is very high, especially with a family history of premature cardiovascular disease, familial hypercholesterolemia should be considered. Secondary causes such as hypothyroidism, diabetes, kidney disease and some medicines may also need assessment. [1]

Diagnostic pathway

Measure the lipid pattern, then place it in the person’s cardiovascular-risk context

The same LDL value can imply different management in people with different levels of baseline cardiovascular risk.

Risk-based assessment
1Order a lipid profileMeasure LDL, HDL, triglycerides and total cholesterol.
2Look for secondary causesReview thyroid, diabetes, kidney disease, medicines and lifestyle where appropriate.
3Estimate cardiovascular riskConsider existing CVD, age, blood pressure, smoking, diabetes and other risk modifiers.
4Set a treatment planUse lifestyle and lipid-lowering treatment according to risk and guideline targets.
LDLKey atherogenic lipidinterpreted by risk
HDLRisk markernot a stand-alone treatment target
TriglyceridesPart of lipid profilevery high values have additional risks

Treatment thresholds and lipid targets depend on baseline cardiovascular risk and whether prevention is primary or secondary. Source [2]

Why LDL cholesterol matters

Persistently elevated LDL cholesterol promotes atherosclerosis, which can narrow arteries and increase the risk of coronary heart disease, heart attack, stroke and peripheral artery disease. Cardiovascular risk rises further when high cholesterol is combined with smoking, hypertension, diabetes or chronic kidney disease. [1]

Treatment and management

Heart-healthy eating, regular physical activity, weight management where appropriate and avoiding tobacco are foundational. The decision to add medicine is based on cardiovascular risk, existing disease and the lipid pattern rather than symptoms. [2]

2 expert notes

When triglycerides are markedly elevated, I treat that as a different lipid-management problem from isolated high LDL. In selected patients, triglyceride-lowering therapy such as a fibrate may be considered, particularly when pancreatitis risk is a concern.

Pregnancy changes the usual lipid-treatment plan. Statins are generally stopped for most pregnant patients, while exceptionally high-risk situations require individualized specialist advice rather than a blanket approach.

Statins are the most widely used medicines for lowering LDL cholesterol and reducing cardiovascular events. NICE recommends risk-based statin treatment for primary prevention and intensive lipid lowering for people with established cardiovascular disease; additional treatments such as ezetimibe, PCSK9-targeting therapies or bempedoic acid may be considered in selected situations. [2]

Treatment & care hub

Lower atherogenic cholesterol in proportion to cardiovascular risk

The goal is prevention of cardiovascular events, not simply changing a laboratory number.

CVD prevention
LifestyleFoundation

Reduce modifiable risk

Diet quality, physical activity, weight management and tobacco avoidance support cardiovascular health.

StatinCommon first-line

Lower LDL and cardiovascular risk

Statins are widely used when guideline-based risk assessment supports medication.

Additional therapySelected patients

Escalate when needed

Ezetimibe and other lipid-lowering medicines may be added when targets are not reached or statins are not suitable.

Follow-upMeasure response

Repeat the lipid profile

Follow-up testing checks response, adherence and whether treatment needs adjustment.

When inherited high cholesterol is suspected

Very high LDL cholesterol, tendon xanthomas or a family history of premature coronary disease can suggest familial hypercholesterolemia. In these cases, earlier specialist assessment and family-based testing may be appropriate. [1]

United States estimate

High total cholesterol remains common in adults

NHANES data show that abnormal cholesterol patterns remain an important cardiovascular risk issue.

CDC/NCHS Data Brief 515, November 2024 ↗
High total cholesterol11.3%August 2021–August 2023
Low HDL-C13.8%
Age 40–59 high total16.7%
MeasureNHANES
Source: CDC/NCHS NHANES. “High total cholesterol” in this report means total cholesterol ≥240 mg/dL and is not equivalent to every form of dyslipidemia.

Common questions

Frequently asked questions

Reference content